Physician profile
Edwin Diaz
NPI 1821755257
$21,279.95
in general payments reported to CMS, 2019-2025
73 companies · $5,956 in 2025
The $5,956 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $5,339 · 2023: $4,828 · 2024: $5,157 · 2025: $5,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $788 · Education: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,666.54 |
| Travel and Lodging | $787.99 |
| Education | $486.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,420.11 | 2023-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $1,681.67 | 2023-2025 | Fasenra, Airsupra, Tezspire |
| Inspire Medical Systems, INC. | $1,478.85 | 2024-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $1,075.77 | 2022-2025 | |
| Amgen INC. | $975.58 | 2022-2025 | Tezspire, Aimovig |
| Abbvie INC. | $803.44 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $723.13 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $618.85 | 2023-2025 | Glassia |
| Inari Medical, INC. | $596.57 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $555.84 | 2023-2025 | Ofev, Jascayd |
| Neurocrine Biosciences, INC. | $502.43 | 2022-2023 | Ingrezza, Ongentys |
| Regeneron Healthcare Solutions, INC. | $473.05 | 2023-2025 | Dupixent |
| Stryker Corporation | $413.22 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Harmony Biosciences LLC | $399.10 | 2022-2025 | Wakix |
| United Therapeutics Corporation | $366.96 | 2023-2025 | Tyvaso, Tyvaso |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $354.81 | 2022-2023 | Zeposia |
| Octapharma USA, INC. | $325.09 | 2022-2023 | Panzyga |
| Lilly USA, LLC | $318.46 | 2022-2023 | Reyvow, Emgality, Amyvid |
| Pfizer INC. | $300.84 | 2022-2023 | |
| Acorda Therapeutics, INC | $297.02 | 2022-2023 | Inbrija |
| Grifols USA, LLC | $290.25 | 2023-2025 | Prolastin-C Liquid |
| Avadel Cns Pharmaceuticals, LLC | $289.10 | 2023-2025 | Lumryz |
| Teva Pharmaceuticals USA, INC. | $285.44 | 2022-2023 | Austedo, Austedo Xr |
| Impel Pharmaceuticals INC. | $278.41 | 2022-2023 | Trudhesa |
| Eisai INC. | $262.81 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $253.81 | 2022-2023 | Ultomiris |
| Sk Life Science, INC. | $244.71 | 2022-2023 | |
| Mdd US Operations, LLC | $236.71 | 2022-2023 | Gocovri |
| Ucb, INC. | $234.62 | 2022-2023 | Briviact |
| Sunovion Pharmaceuticals INC. | $233.78 | 2022 | |
| Genzyme Corporation | $232.70 | 2023-2025 | |
| Kyowa Kirin, INC. | $207.86 | 2022-2023 | Nourianz |
| Biogen, INC. | $205.41 | 2022-2023 | Tysabri, Vumerity |
| Amneal Pharmaceuticals LLC | $193.90 | 2022-2023 | Rytary |
| Novartis Pharmaceuticals Corporation | $187.06 | 2023-2025 | |
| Verona Pharma, INC. | $180.27 | 2025 | Ohtuvayre |
| Lundbeck LLC | $176.51 | 2022-2023 | Vyepti |
| E.R. Squibb & Sons, L.L.C. | $166.90 | 2022 | |
| Corium, LLC | $160.71 | 2022-2023 | Adlarity |
| Actelion Pharmaceuticals US, INC. | $159.76 | 2024-2025 | Opsumit, Uptravi |
| Sumitomo Pharma America, INC. | $148.34 | 2023 | Aptiom |
| Otsuka America Pharmaceutical, INC. | $145.57 | 2023 | Nuedexta, Rexulti |
| Insmed, INC. | $144.92 | 2025 | Arikayce |
| Janssen Pharmaceuticals, INC | $142.26 | 2022-2024 | Xarelto, Ponvory |
| Merck Sharp & Dohme LLC | $141.79 | 2024-2025 | Winrevair |
| Banner Life Sciences, LLC | $101.98 | 2022-2023 | |
| Electromed, INC. | $101.81 | 2023-2025 | Smartvest |
| Ani Pharmaceuticals, INC. | $100.66 | 2022-2025 | Purified Cortrophin Gel |
| Azurity Pharmaceuticals, INC. | $97.96 | 2023-2024 | Horizant, Horizant |
| Sanofi-Aventis U.S. LLC | $84.99 | 2025 | |
| Avanir Pharmaceuticals, INC. | $82.81 | 2022 | |
| Argenx US, INC. | $81.00 | 2022-2023 | Vyvgart |
| Horizon Therapeutics Plc | $75.17 | 2022-2023 | Uplizna |
| Mallinckrodt Hospital Products INC. | $65.06 | 2024-2025 | Acthar |
| Philips North America LLC | $58.77 | 2024-2025 | (Ae4) Secretion Management, Image Management Subscription |
| Supernus Pharmaceuticals, INC. | $57.95 | 2022 | |
| Baxter Healthcare | $54.89 | 2024 | Hillrom - Monarch Airway Clearance System |
| Csl Behring | $47.92 | 2022 | |
| Mylan Specialty L.P. | $43.82 | 2024 | Yupelri |
| Scilex Pharmaceuticals INC. | $42.92 | 2023 | Ztlido |
| Upsher-Smith Laboratories LLC | $37.37 | 2022-2023 | |
| Neurelis, INC. | $32.12 | 2022 | |
| Nevro Corp. | $28.81 | 2022-2023 | Senza |
| Emd Serono, INC. | $27.31 | 2023 | Mavenclad |
| Catalyst Pharmaceuticals, INC. | $25.53 | 2023 | Fycompa |
| Tg Therapeutics, INC. | $22.80 | 2023 | |
| 3b Medical, INC. | $22.22 | 2024 | Luna |
| Avion Pharmaceuticals | $21.47 | 2023 | Dhivy |
| Boston Scientific Corporation | $19.20 | 2023 | |
| Phadia US INC. | $17.44 | 2025 | Immunocap |
| Conmed Corporation | $15.69 | 2024 | Airseal |
| Xeris Pharmaceuticals, INC. | $14.88 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.